iBio
IBIO
15 hedge funds and large institutions have $510K invested in iBio in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
6% less funds holding
Funds holding: 16 → 15 (-1)
50% less capital invested
Capital invested by funds: $1.01M → $510K (-$502K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.28K |
| 2 |
Bank of New York Mellon
New York
|
+$1.28K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$37K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$16.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $294K | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $60K | – | – | – |
|
3
BlackRock
New York
| $32K | – | – | – |
|
|
S
4
SignatureFD
Atlanta,
Georgia
| $27K | – | – | – |
|
5
HighTower Advisors
Chicago,
Illinois
| $24K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $16K | -$5.13K | -4 | -18% |
|
|
ACP
7
Aveo Capital Partners
Englewood,
Colorado
| $13K | – | – | – |
|
|
8
Bank of New York Mellon
New York
| $13K | +$1.28K | +1 | +7% |
|
9
Northern Trust
Chicago,
Illinois
| $12K | – | – | – |
|
|
TSS
10
Two Sigma Securities
New York
| $7K | -$16.7K | -13 | -62% |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
12
Morgan Stanley
New York
| $3K | – | – | – |
|
13
State Street
Boston,
Massachusetts
| $2K | – | – | – |
|
|
UAS
14
United Asset Strategies
Garden City,
New York
| $2K | – | – | – |
|
|
15
Bank of America
Charlotte,
North Carolina
| $1K | +$1.28K | +1 | New |
|
|
VF
16
Virtu Financial
New York
| – | -$37K | -23 | Closed |
|
|
17
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$31K | -19 | Closed |
|
IBIO Hedge Fund Activity: Q4 2017 in Review
15 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2017, worth a combined $510K — down 50% from $1.01M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IBIO and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was Bank of America, opening a new position worth an estimated $1.28K. The largest seller was Virtu Financial, exiting entirely with an estimated $37K sold.
- 15 institutional investors held iBio (IBIO) as of Q4 2017, down from 16 in Q3 2017.
- Funds reported $510K of iBio stock for Q4 2017, down 50% quarter-over-quarter.
- 1 fund opened new iBio positions in Q4 2017 and 2 closed out, a net change of -1 holder.
- The largest iBio buyer in Q4 2017 was Bank of America, an estimated $1.28K added.
- The largest iBio seller in Q4 2017 was Virtu Financial, an estimated $37K sold.
Based on aggregated 13F filings for Q4 2017.